Georgiamune Inc
3 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| The Purpose of the Study is to Evaluate the Safety, Tolerability and Pharmacokinetics of Single-ascending and Multiple-ascending Doses of GIM-407 (NCT06536101) | Georgiamune Inc | 2024-09-02 |
| Safety and Tolerability Study of GIM-531 in Advanced Solid Tumors (NCT06425926) | Georgiamune Inc | 2024-05-09 |
| Safety and Tolerability Study of GIM-122 in Subjects With Advanced Solid Malignancies (NCT06028074) | Georgiamune Inc | 2023-12-12 |
Track Georgiamune Inc automatically
Every clearance here is in the API, with alerts when new ones post.